12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga_article·15 hours agoNEO+13.96%AMIX+66.18%
NeuroPace's Panel Track Supplement Not Approvable in Current Form, FDA SaysMorningStar·1 day ago, 05:42 PMNPCE-10.91%
12 Health Care Stocks Moving In Tuesday's After-Market Sessionbenzinga_article·1 day ago, 04:06 PMVTAK+1.00%NPCE-10.91%
NeuroPace says FDA deems epilepsy label expansion filing not approvable in current formPUBT·1 day ago, 03:33 PMNPCE-10.91%
Beyond Big Tech: 10 Under-the-Radar US Stocks Making Moves This WeekGlobal Report·Jul 9 at 09:02 PMCELG.RT0.00%RZLV-3.03%
Capital Rotates into Niche Tech and Healthcare RestructuringsGlobal Report·Jul 9 at 05:03 AMCVBF+0.13%FHTX-7.60%
US Market’s Unclassified Tickers Highlight Shifting Global Supply ChainsGlobal Report·Jul 3 at 06:35 AMSOUL.RT0.00%TROO-5.98%
Tech Niche Leaders Secure Exabyte Deals and $1.2B Buyouts in AI PushGlobal Report·Jul 3 at 04:03 AMNPCE-10.91%NOVT-2.72%
The Quiet Infrastructure Boom: From Lithium Refineries to Legacy TankersGlobal Report·Jul 3 at 03:32 AMABAT-5.96%NIU-3.77%
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting | NPCE Stock NewsStockTitan·May 28 at 11:05 PMNPCE-10.91%
